The Market Reports

Index

1 Femoral Arterial Cannulae Market Overview
1.1 Product Overview and Scope of Femoral Arterial Cannulae
1.2 Femoral Arterial Cannulae Segment by Type
1.2.1 Global Femoral Arterial Cannulae Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Unipolar Femoral Arterial Cannulae
1.2.3 Bipolar Femoral Arterial Cannulae
1.3 Femoral Arterial Cannulae Segment by Application
1.3.1 Femoral Arterial Cannulae Sales Comparison by Application: (2021-2027)
1.3.2 Traditional cardiopulmonary bypass surgery
1.3.3 Extracorporeal Membrane Pulmonary Oxygenation (ECMO)
1.3.4 Hemodialysis
1.3.5 other
1.4 Global Femoral Arterial Cannulae Market Size Estimates and Forecasts
1.4.1 Global Femoral Arterial Cannulae Revenue 2016-2027
1.4.2 Global Femoral Arterial Cannulae Sales 2016-2027
1.4.3 Femoral Arterial Cannulae Market Size by Region: 2016 Versus 2021 Versus 2027

2 Femoral Arterial Cannulae Market Competition by Manufacturers
2.1 Global Femoral Arterial Cannulae Sales Market Share by Manufacturers (2016-2021)
2.2 Global Femoral Arterial Cannulae Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Femoral Arterial Cannulae Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Femoral Arterial Cannulae Manufacturing Sites, Area Served, Product Type
2.5 Femoral Arterial Cannulae Market Competitive Situation and Trends
2.5.1 Femoral Arterial Cannulae Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Femoral Arterial Cannulae Players Market Share by Revenue
2.5.3 Global Femoral Arterial Cannulae Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Femoral Arterial Cannulae Retrospective Market Scenario by Region
3.1 Global Femoral Arterial Cannulae Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Femoral Arterial Cannulae Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Femoral Arterial Cannulae Market Facts & Figures by Country
3.3.1 North America Femoral Arterial Cannulae Sales by Country
3.3.2 North America Femoral Arterial Cannulae Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Femoral Arterial Cannulae Market Facts & Figures by Country
3.4.1 Europe Femoral Arterial Cannulae Sales by Country
3.4.2 Europe Femoral Arterial Cannulae Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Femoral Arterial Cannulae Market Facts & Figures by Region
3.5.1 Asia Pacific Femoral Arterial Cannulae Sales by Region
3.5.2 Asia Pacific Femoral Arterial Cannulae Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Femoral Arterial Cannulae Market Facts & Figures by Country
3.6.1 Latin America Femoral Arterial Cannulae Sales by Country
3.6.2 Latin America Femoral Arterial Cannulae Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Femoral Arterial Cannulae Market Facts & Figures by Country
3.7.1 Middle East and Africa Femoral Arterial Cannulae Sales by Country
3.7.2 Middle East and Africa Femoral Arterial Cannulae Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Femoral Arterial Cannulae Historic Market Analysis by Type
4.1 Global Femoral Arterial Cannulae Sales Market Share by Type (2016-2021)
4.2 Global Femoral Arterial Cannulae Revenue Market Share by Type (2016-2021)
4.3 Global Femoral Arterial Cannulae Price by Type (2016-2021)

5 Global Femoral Arterial Cannulae Historic Market Analysis by Application
5.1 Global Femoral Arterial Cannulae Sales Market Share by Application (2016-2021)
5.2 Global Femoral Arterial Cannulae Revenue Market Share by Application (2016-2021)
5.3 Global Femoral Arterial Cannulae Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Femoral Arterial Cannulae Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Medtronic Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Edward Lifescience
6.2.1 Edward Lifescience Corporation Information
6.2.2 Edward Lifescience Description and Business Overview
6.2.3 Edward Lifescience Femoral Arterial Cannulae Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Edward Lifescience Product Portfolio
6.2.5 Edward Lifescience Recent Developments/Updates
6.3 LivaNova
6.3.1 LivaNova Corporation Information
6.3.2 LivaNova Description and Business Overview
6.3.3 LivaNova Femoral Arterial Cannulae Sales, Revenue and Gross Margin (2016-2021)
6.3.4 LivaNova Product Portfolio
6.3.5 LivaNova Recent Developments/Updates
6.4 Surge Cardiovascular
6.4.1 Surge Cardiovascular Corporation Information
6.4.2 Surge Cardiovascular Description and Business Overview
6.4.3 Surge Cardiovascular Femoral Arterial Cannulae Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Surge Cardiovascular Product Portfolio
6.4.5 Surge Cardiovascular Recent Developments/Updates
6.5 Kangxin Medical
6.5.1 Kangxin Medical Corporation Information
6.5.2 Kangxin Medical Description and Business Overview
6.5.3 Kangxin Medical Femoral Arterial Cannulae Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Kangxin Medical Product Portfolio
6.5.5 Kangxin Medical Recent Developments/Updates
6.6 Charlice Medical
6.6.1 Charlice Medical Corporation Information
6.6.2 Charlice Medical Description and Business Overview
6.6.3 Charlice Medical Femoral Arterial Cannulae Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Charlice Medical Product Portfolio
6.6.5 Charlice Medical Recent Developments/Updates
6.7 Xenios AG
6.6.1 Xenios AG Corporation Information
6.6.2 Xenios AG Description and Business Overview
6.6.3 Xenios AG Femoral Arterial Cannulae Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Xenios AG Product Portfolio
6.7.5 Xenios AG Recent Developments/Updates

7 Femoral Arterial Cannulae Manufacturing Cost Analysis
7.1 Femoral Arterial Cannulae Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Femoral Arterial Cannulae
7.4 Femoral Arterial Cannulae Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Femoral Arterial Cannulae Distributors List
8.3 Femoral Arterial Cannulae Customers

9 Femoral Arterial Cannulae Market Dynamics
9.1 Femoral Arterial Cannulae Industry Trends
9.2 Femoral Arterial Cannulae Growth Drivers
9.3 Femoral Arterial Cannulae Market Challenges
9.4 Femoral Arterial Cannulae Market Restraints

10 Global Market Forecast
10.1 Femoral Arterial Cannulae Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Femoral Arterial Cannulae by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Femoral Arterial Cannulae by Type (2022-2027)
10.2 Femoral Arterial Cannulae Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Femoral Arterial Cannulae by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Femoral Arterial Cannulae by Application (2022-2027)
10.3 Femoral Arterial Cannulae Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Femoral Arterial Cannulae by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Femoral Arterial Cannulae by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Femoral Arterial Cannulae Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Femoral Arterial Cannulae Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Femoral Arterial Cannulae Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Femoral Arterial Cannulae Covered in This Study
Table 5. Global Femoral Arterial Cannulae Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Femoral Arterial Cannulae Sales Share by Manufacturers (2016-2021)
Table 7. Global Femoral Arterial Cannulae Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Femoral Arterial Cannulae Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Femoral Arterial Cannulae Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Femoral Arterial Cannulae Manufacturing Sites and Area Served
Table 11. Manufacturers Femoral Arterial Cannulae Product Type
Table 12. Global Femoral Arterial Cannulae Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Femoral Arterial Cannulae by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Femoral Arterial Cannulae as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Femoral Arterial Cannulae Sales by Region (2016-2021) & (K Units)
Table 16. Global Femoral Arterial Cannulae Sales Market Share by Region (2016-2021)
Table 17. Global Femoral Arterial Cannulae Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Femoral Arterial Cannulae Sales by Country (2016-2021) & (K Units)
Table 19. North America Femoral Arterial Cannulae Sales Market Share by Country (2016-2021)
Table 20. North America Femoral Arterial Cannulae Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Femoral Arterial Cannulae Revenue Market Share by Country (2016-2021)
Table 22. Europe Femoral Arterial Cannulae Sales by Country (2016-2021) & (K Units)
Table 23. Europe Femoral Arterial Cannulae Sales Market Share by Country (2016-2021)
Table 24. Europe Femoral Arterial Cannulae Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Femoral Arterial Cannulae Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Femoral Arterial Cannulae Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Femoral Arterial Cannulae Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Femoral Arterial Cannulae Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Femoral Arterial Cannulae Revenue Market Share by Region (2016-2021)
Table 30. Latin America Femoral Arterial Cannulae Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Femoral Arterial Cannulae Sales Market Share by Country (2016-2021)
Table 32. Latin America Femoral Arterial Cannulae Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Femoral Arterial Cannulae Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Femoral Arterial Cannulae Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Femoral Arterial Cannulae Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Femoral Arterial Cannulae Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Femoral Arterial Cannulae Revenue Market Share by Country (2016-2021)
Table 38. Global Femoral Arterial Cannulae Sales (K Units) by Type (2016-2021)
Table 39. Global Femoral Arterial Cannulae Sales Market Share by Type (2016-2021)
Table 40. Global Femoral Arterial Cannulae Revenue (Million US$) by Type (2016-2021)
Table 41. Global Femoral Arterial Cannulae Revenue Share by Type (2016-2021)
Table 42. Global Femoral Arterial Cannulae Price (US$/Unit) by Type (2016-2021)
Table 43. Global Femoral Arterial Cannulae Sales (K Units) by Application (2016-2021)
Table 44. Global Femoral Arterial Cannulae Sales Market Share by Application (2016-2021)
Table 45. Global Femoral Arterial Cannulae Revenue (Million US$) by Application (2016-2021)
Table 46. Global Femoral Arterial Cannulae Revenue Share by Application (2016-2021)
Table 47. Global Femoral Arterial Cannulae Price (US$/Unit) by Application (2016-2021)
Table 48. Medtronic Corporation Information
Table 49. Medtronic Description and Business Overview
Table 50. Medtronic Femoral Arterial Cannulae Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Medtronic Femoral Arterial Cannulae Product
Table 52. Medtronic Recent Developments/Updates
Table 53. Edward Lifescience Corporation Information
Table 54. Edward Lifescience Description and Business Overview
Table 55. Edward Lifescience Femoral Arterial Cannulae Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Edward Lifescience Femoral Arterial Cannulae Product
Table 57. Edward Lifescience Recent Developments/Updates
Table 58. LivaNova Corporation Information
Table 59. LivaNova Description and Business Overview
Table 60. LivaNova Femoral Arterial Cannulae Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. LivaNova Femoral Arterial Cannulae Product
Table 62. LivaNova Recent Developments/Updates
Table 63. Surge Cardiovascular Corporation Information
Table 64. Surge Cardiovascular Description and Business Overview
Table 65. Surge Cardiovascular Femoral Arterial Cannulae Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Surge Cardiovascular Femoral Arterial Cannulae Product
Table 67. Surge Cardiovascular Recent Developments/Updates
Table 68. Kangxin Medical Corporation Information
Table 69. Kangxin Medical Description and Business Overview
Table 70. Kangxin Medical Femoral Arterial Cannulae Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Kangxin Medical Femoral Arterial Cannulae Product
Table 72. Kangxin Medical Recent Developments/Updates
Table 73. Charlice Medical Corporation Information
Table 74. Charlice Medical Description and Business Overview
Table 75. Charlice Medical Femoral Arterial Cannulae Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Charlice Medical Femoral Arterial Cannulae Product
Table 77. Charlice Medical Recent Developments/Updates
Table 78. Xenios AG Corporation Information
Table 79. Xenios AG Description and Business Overview
Table 80. Xenios AG Femoral Arterial Cannulae Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Xenios AG Femoral Arterial Cannulae Product
Table 82. Xenios AG Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Femoral Arterial Cannulae Distributors List
Table 86. Femoral Arterial Cannulae Customers List
Table 87. Femoral Arterial Cannulae Market Trends
Table 88. Femoral Arterial Cannulae Growth Drivers
Table 89. Femoral Arterial Cannulae Market Restraints
Table 90. Global Femoral Arterial Cannulae Sales Forecast by Type (2022-2027) & (K Units)
Table 91. Global Femoral Arterial Cannulae Sales Market Share Forecast by Type (2022-2027)
Table 92. Global Femoral Arterial Cannulae Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global Femoral Arterial Cannulae Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global Femoral Arterial Cannulae Sales Forecast by Application (2022-2027) & (K Units)
Table 95. Global Femoral Arterial Cannulae Sales Market Share Forecast by Application (2022-2027)
Table 96. Global Femoral Arterial Cannulae Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global Femoral Arterial Cannulae Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global Femoral Arterial Cannulae Sales Forecast by Region (2022-2027) & (K Units)
Table 99. Global Femoral Arterial Cannulae Sales Market Share Forecast by Region (2022-2027)
Table 100. Global Femoral Arterial Cannulae Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global Femoral Arterial Cannulae Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Femoral Arterial Cannulae
Figure 2. Global Femoral Arterial Cannulae Market Share by Type in 2020 & 2027
Figure 3. Unipolar Femoral Arterial Cannulae Product Picture
Figure 4. Bipolar Femoral Arterial Cannulae Product Picture
Figure 5. Global Femoral Arterial Cannulae Market Share by Application in 2020 & 2027
Figure 6. Traditional cardiopulmonary bypass surgery
Figure 7. Extracorporeal Membrane Pulmonary Oxygenation (ECMO)
Figure 8. Hemodialysis
Figure 9. other
Figure 10. Global Femoral Arterial Cannulae Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Femoral Arterial Cannulae Market Size 2016-2027 (US$ Million)
Figure 12. Global Femoral Arterial Cannulae Sales 2016-2027 (K Units)
Figure 13. Global Femoral Arterial Cannulae Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Femoral Arterial Cannulae Sales Share by Manufacturers in 2020
Figure 15. Global Femoral Arterial Cannulae Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Femoral Arterial Cannulae Players: Market Share by Revenue in 2020
Figure 17. Femoral Arterial Cannulae Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Femoral Arterial Cannulae Sales Market Share by Region (2016-2021)
Figure 19. Global Femoral Arterial Cannulae Sales Market Share by Region in 2020
Figure 20. Global Femoral Arterial Cannulae Revenue Market Share by Region (2016-2021)
Figure 21. Global Femoral Arterial Cannulae Revenue Market Share by Region in 2020
Figure 22. U.S. Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Femoral Arterial Cannulae Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Femoral Arterial Cannulae by Type (2016-2021)
Figure 47. Sales Market Share of Femoral Arterial Cannulae by Application (2016-2021)
Figure 48. Sales Market Share of Femoral Arterial Cannulae by Application in 2020
Figure 49. Revenue Share of Femoral Arterial Cannulae by Application (2016-2021)
Figure 50. Revenue Share of Femoral Arterial Cannulae by Application in 2020
Figure 51. Manufacturing Cost Structure of Femoral Arterial Cannulae
Figure 52. Manufacturing Process Analysis of Femoral Arterial Cannulae
Figure 53. Femoral Arterial Cannulae Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed